Epithelioid Sarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2020-01-23
FDA Approved: TAZVERIK — Original Application (Epizyme, Inc.)
The FDA approved the original application for TAZVERIK (tazemetostat) by Epizyme, Inc. for epithelioid sarcoma, marking the first approved i…